N-(2-{4-[6-(3,4-dimethoxyphenyl)pyridazin-3-yl]-1,4-diazepan-1-yl}-2-oxoethyl)-N-[(furan-2-yl)methyl]-2-phenylacetamide
Chemical Structure Depiction of
N-(2-{4-[6-(3,4-dimethoxyphenyl)pyridazin-3-yl]-1,4-diazepan-1-yl}-2-oxoethyl)-N-[(furan-2-yl)methyl]-2-phenylacetamide
N-(2-{4-[6-(3,4-dimethoxyphenyl)pyridazin-3-yl]-1,4-diazepan-1-yl}-2-oxoethyl)-N-[(furan-2-yl)methyl]-2-phenylacetamide
Compound characteristics
| Compound ID: | V020-0731 |
| Compound Name: | N-(2-{4-[6-(3,4-dimethoxyphenyl)pyridazin-3-yl]-1,4-diazepan-1-yl}-2-oxoethyl)-N-[(furan-2-yl)methyl]-2-phenylacetamide |
| Molecular Weight: | 569.66 |
| Molecular Formula: | C32 H35 N5 O5 |
| Salt: | not_available |
| Smiles: | COc1ccc(cc1OC)c1ccc(nn1)N1CCCN(CC1)C(CN(Cc1ccco1)C(Cc1ccccc1)=O)=O |
| Stereo: | ACHIRAL |
| logP: | 3.6664 |
| logD: | 3.5534 |
| logSw: | -3.9054 |
| Hydrogen bond acceptors count: | 9 |
| Polar surface area: | 79.579 |
| InChI Key: | FWAPGSQARHHDRR-UHFFFAOYSA-N |